CLIENT ALERT: Multi-Pharmacy 340B Contract Pharmacy Programs in Serious Jeopardy After Third Circuit Ruling
The United States Court of Appeals for the Third Circuit ruled on Monday in favor of drug manufacturers AstraZeneca, Sanofi and Novo Nordisk in their challenge against attempts by the Health Resources [...]